摘要
L-核糖经1-位甲基化、乙酰化保护、糖苷化和脱保护制得1-(β-L-呋喃核糖基)-5-甲基尿嘧啶(7),7与丙酰溴进行酰化溴代、次磷酸脱溴,最后脱除糖基上保护基制得抗病毒药替比夫定,总收率约23%(以L-核糖计)。
Telbivudine, an antiviral agent, was synthesized from L-ribose by methylation, protection, reaction with silyl-5-methyluracil and deprotection to give 1-(β-L-ribofuranosyl)-5-methyluracil, which was subjected to acylation and bromination with propionyl bromide, debromination with hypophosphorous acid and then deprotection with an overall yield of about 23 % (based on L-ribose).
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2010年第6期401-403,共3页
Chinese Journal of Pharmaceuticals
关键词
替比夫定
抗病毒药
核苷
合成
telbivudine
antiviral agent
nucleoside
synthesis